登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式(希尔记法):
C18H17NO5
化学文摘社编号:
分子量:
327.33
UNSPSC Code:
51111800
MDL number:
NACRES:
NA.77
SMILES string
N(c2c(cccc2)C(=O)O)C(=O)\C=C\c1cc(c(cc1)OC)OC
InChI
1S/C18H17NO5/c1-23-15-9-7-12(11-16(15)24-2)8-10-17(20)19-14-6-4-3-5-13(14)18(21)22/h3-11H,1-2H3,(H,19,20)(H,21,22)/b10-8+
InChI key
NZHGWWWHIYHZNX-CSKARUKUSA-N
description
Merck USA index - 14, 9570
assay
≥95% (HPLC)
form
solid
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze, protect from light
color
pale yellow
solubility
DMSO: 200 mg/mL
storage temp.
−20°C
Quality Level
正在寻找类似产品? 访问 产品对比指南
General description
An anthranilic acid analog that acts as a potent inhibitor of VEGF- and vascular permeability factor-induced angiogenesis and collagen synthesis. Inhibits VEGF- and PMA-stimulated PKC activity in retinal capillary endothelial cells without affecting the VEGF binding or VEGF receptor phosphorylation. Also has antiallergic, anti-inflammatory, and antiproliferative properties. Induces Ca2+ mobilization in vascular smooth muscle.
Biochem/physiol Actions
Primary Target
VEGF- and vascular permeability factor-induced angiogenesis and collagen synthesis
VEGF- and vascular permeability factor-induced angiogenesis and collagen synthesis
Preparation Note
Following reconstitution, aliquot and freeze (-20°C).
Other Notes
Koyama, S., et al. 1999. Br. J. Pharmacol. 127, 537.
Isaji, M., et al. 1998. Life Sci. 63, PL71.
Isaji, M., et al. 1997. Br. J. Pharmacol. 122, 1061.
Isaji, M., et al. 1998. Life Sci. 63, PL71.
Isaji, M., et al. 1997. Br. J. Pharmacol. 122, 1061.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Toxicity: Harmful (C)
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持